We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
-4.53%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$125M
AUM Growth
-$7.12M
Cap. Flow
+$559K
Cap. Flow %
0.45%
Top 10 Hldgs %
75.11%
Holding
50
New
Increased
17
Reduced
2
Closed
1

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$202K
2
MSFT icon
Microsoft
MSFT
+$121K
3
ADBE icon
Adobe
ADBE
+$76.7K

Sector Composition

Rank Sector Weight
1 Healthcare 50.12%
2 Technology 27.87%
3 Communication Services 8.15%
4 Financials 3.29%
5 Consumer Discretionary 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWR icon
26
Quanta Services
PWR
$102B
$751K 0.6%
33,300
+1,000
+3% +$19.8K
PEG icon
27
Public Service Enterprise Group
PEG
$38.2B
$718K 0.57%
15,222
V icon
28
Visa
V
$683B
$704K 0.56%
9,200
AMZN icon
29
Amazon
AMZN
$3.06T
$665K 0.53%
22,400
INTC icon
30
Intel
INTC
$459B
$664K 0.53%
20,522
+100
+0.5% +$3.07K
MON
31
DELISTED
Monsanto Co
MON
$643K 0.51%
7,325
AMGN icon
32
Amgen
AMGN
$204B
$526K 0.42%
3,505
BEN icon
33
Franklin Resources
BEN
$17.9B
$498K 0.4%
12,750
IBM icon
34
IBM
IBM
$213B
$465K 0.37%
3,211
BMY icon
35
Bristol-Myers Squibb
BMY
$134B
$464K 0.37%
7,270
PEP icon
36
PepsiCo
PEP
$191B
$433K 0.35%
4,225
SLB icon
37
SLB Ltd
SLB
$73.2B
$417K 0.33%
5,650
MRK icon
38
Merck
MRK
$316B
$343K 0.27%
6,798
MCHP icon
39
Microchip Technology
MCHP
$40.8B
$339K 0.27%
14,050
HD icon
40
Home Depot
HD
$339B
$334K 0.27%
2,500
LLY icon
41
Eli Lilly
LLY
$1,000B
$332K 0.27%
4,614
UNFI icon
42
United Natural Foods
UNFI
$2.87B
$314K 0.25%
7,800
CTSH icon
43
Cognizant
CTSH
$24.9B
$307K 0.25%
4,900
VAR
44
DELISTED
Varian Medical Systems, Inc.
VAR
$276K 0.22%
3,934
BNY
45
Bank of New York Mellon
BNY
$106B
$258K 0.21%
7,000
CAT icon
46
Caterpillar
CAT
$382B
$253K 0.2%
3,300
STJ
47
DELISTED
St Jude Medical
STJ
$245K 0.2%
4,450
ILMN icon
48
Illumina
ILMN
$29.9B
$227K 0.18%
1,439
BSX icon
49
Boston Scientific
BSX
$70.2B
$209K 0.17%
11,104
GILD icon
50
Gilead Sciences
GILD
$163B
-2,000
Closed -$202K

Similar funds

Bourne Lent Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, Bourne Lent Asset Management held 50 positions worth $125M, down 5.4% from $132M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2%. Bourne Lent Asset Management opened no new positions and exited 1, leaving the 50-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 54% a quarter earlier, followed by Technology and Communication Services.

  • Bourne Lent Asset Management added most to Pacific Biosciences in Q1 2016, an estimated $183K increase.
  • Bourne Lent Asset Management's biggest Q1 2016 reduction was Microsoft, cutting an estimated $121K.
  • Bourne Lent Asset Management fully exited Gilead Sciences in Q1 2016, selling an estimated $202K.
  • Bourne Lent Asset Management's ten largest holdings make up 75% of its $125M portfolio in Q1 2016.
  • Bourne Lent Asset Management opened 0 new positions and closed 1 in Q1 2016.
  • Bourne Lent Asset Management's portfolio value fell 5.4% quarter-over-quarter to $125M.

Based on Bourne Lent Asset Management's 13F filing for Q1 2016, filed 2 May 2016.